The level of government review necessary before a high-risk device is launched in markets in the European Union was a main point of contention at a workshop convened last month by the European Parliament’s Environment, Public Health and Food Safety Committee.
The Committee held the session Feb. 26 to address a proposal issued last year by the European Commission to impose reforms on EU device oversight
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?